Drug Resistance in Oncology (eBook, PDF)
Redaktion: Bernal, S.
55,95 €
55,95 €
inkl. MwSt.
Sofort per Download lieferbar
28 °P sammeln
55,95 €
Als Download kaufen
55,95 €
inkl. MwSt.
Sofort per Download lieferbar
28 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
55,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
28 °P sammeln
Drug Resistance in Oncology (eBook, PDF)
Redaktion: Bernal, S.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This timely new reference integrates the latest clinical results and laboratory studies on the resistance of specific cancers to chemotherapeutic drugs-covering drug resistance in lung, breast, ovary, and colon cancer as well as hematological malignancies.
- Geräte: PC
- mit Kopierschutz
- eBook Hilfe
- Größe: 29.38MB
Andere Kunden interessierten sich auch für
- Neville WillmottMicrospheres and Regional Cancer Therapy (eBook, PDF)261,95 €
- Jerome Z. LittNeurological Drug Reactions and Interactions (eBook, PDF)89,95 €
- Litt's Drug Eruption & Reaction Manual (eBook, PDF)157,95 €
- Drug Therapy for Stroke Prevention (eBook, PDF)120,95 €
- Drug-Induced Liver Disease (eBook, PDF)59,95 €
- Polymers in Drug Delivery (eBook, PDF)62,95 €
- Organ Specific Drug Delivery and Targeting to the Lungs (eBook, PDF)55,95 €
-
-
-
This timely new reference integrates the latest clinical results and laboratory studies on the resistance of specific cancers to chemotherapeutic drugs-covering drug resistance in lung, breast, ovary, and colon cancer as well as hematological malignancies.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 416
- Erscheinungstermin: 21. August 1997
- Englisch
- ISBN-13: 9781420002096
- Artikelnr.: 54258754
- Verlag: Taylor & Francis
- Seitenzahl: 416
- Erscheinungstermin: 21. August 1997
- Englisch
- ISBN-13: 9781420002096
- Artikelnr.: 54258754
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
S. Bernal
Respiratory Cancer
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the
Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E.
Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and
Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity
Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal,
Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca
and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J.
Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human
Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward,
Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in
Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D.
Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller,
Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the
Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E.
Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and
Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity
Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal,
Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca
and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J.
Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human
Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward,
Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in
Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D.
Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller,
Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher
Respiratory Cancer
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the
Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E.
Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and
Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity
Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal,
Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca
and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J.
Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human
Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward,
Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in
Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D.
Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller,
Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher
Chemotherapy Resistance in Small Cell Lung Cancer: Consequences for the
Clinician and Future Prospects, Bonne Biesma, Egbert F. Smit, and Pieter E.
Postmus
Multidrug Resistance in Small Cell Lung Cancer, Shelagh E. L. Mirski and
Susan P. C. Cole
Correlations Between Clinical Outcomes and In Vitro Chemosensitivity
Testing in Non-Small Cell Lung Cancer (NSCLC), David W. Wilbur
Liposomal Formulations of Chemotherapeutic Drugs, Samuel D. Bernal,
Yuk-Chor Wong, Romulo de Villa, and Gloria Bernas
Breast Cancer
Tamoxifen Resistance and Breast Cancer, Lin Soe and Michael W. DeGregorio
Breast Cancer Resistance to Endocrine Therapy, Per E. Lønning
Heat Shock Proteins and Drug Resistance in Breast Cancer, Daniel R. Ciocca
and Laura M. Vargas Roig
Other Epithelial Cancers
Overcoming Drug Resistance in Ovarian Cancer, P. H. B. Willemse, G. J.
Veldhuis, A. G. J. van der Zee, and E. G. E. de Vries
Protein Kinase C Activation and the Intrinsic Drug Resistance of Human
Colon Cancer, Catherine A. O'Brian, Karen R. Gravitt, Nancy E. Ward,
Krishna P. Guta, Philip J. Bergman, and Constantin G. Ioannides
Hematological Malignancies
Clinical Relevance of P-Glycoprotein-Related Multidrug Resistance in
Hematological Malignancies, Petra C. Pasman and Harry C. Schouten
Prediction of Cytotoxic Drug Resistance in Acute Leukemia, Rolf Larsson
Mechanisms of Drug Resistance
Determinants of Estramustine Resistance, Lisa A. Speicher and Kenneth D.
Tew
Strategies for Overcoming Anthracycline Resistance, Daniel J. Booser
Cellular Mechanisms of Cisplatin Resistance, Jeroen Oldeburg and Gerrit Los
Radiation Response in Chemotherapy-Resistant Tumors, Patrick Miller,
Michael Nejad, and David S. Shimm
Preclinical In Vivo Models of Drug Resistance, Beverly A. Teicher